# Scalp Nerve Block on Emergence Agitation

> **NCT02428283** · PHASE4 · COMPLETED · sponsor: **Ajou University School of Medicine** · enrollment: 44 (actual)

## Conditions studied

- Agitation

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Remifentanil
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT02428283
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02428283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02428283, "Scalp Nerve Block on Emergence Agitation". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02428283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*